Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Renalytix plc - American Depositary Shares (NQ:RNLX)

0.2071 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Renalytix plc - American Depositary Shares

< Previous 1 2 Next >
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Renalytix plc
Via GlobeNewswire
Renalytix announces a c.$20.3 million private placement
From Renalytix plc
Via GlobeNewswire
Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States
Award for consortium of industry, academic and clinical research leaders to develop personalized drug response tests in chronic kidney disease 
From Renalytix plc
Via GlobeNewswire
Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems
Significant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease 
From Renalytix AI, Inc.
Via GlobeNewswire
Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes
First-in-class bioprognostic™ KidneyIntelX provided clear direction for primary care physicians to slow or stop progression of chronic kidney disease in adult diabetes patients 
From Renalytix AI, Inc.
Via GlobeNewswire
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023
From Renalytix AI, Inc.
Via GlobeNewswire
Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease
From Renalytix AI, Inc.
Via GlobeNewswire
Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30
From Renalytix plc
Via GlobeNewswire
Renalytix to Present at Stifel Healthcare Conference
From Renalytix plc
Via GlobeNewswire
Renalytix Reports Full Year Fiscal 2022 Results
From Renalytix plc
Via GlobeNewswire
MarketBeat Podcast, 3 Small Caps With Big Upside
Today on The MarketBeat Podcast is Randy Baron, portfolio manager at Pinnacle Associates. Three stocks Randy discusses today have small market capitalizations. 
Via MarketBeat
Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31
From Renalytix plc
Via GlobeNewswire
KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology
Four presentations, including first clinical utility findings from multi-year real world evidence results from a major healthcare system underscore value of KidneyIntelX™ platform in improving cost... 
From Renalytix plc
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.